80 related articles for article (PubMed ID: 6833815)
21. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
22. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
23. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
Sepúlveda C; Prado R
Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
[TBL] [Abstract][Full Text] [Related]
24. Cervical cancer screening program of Paraná: cost-effective model in a developing country.
Bleggi Torres LF; Werner B; Totsugui J; Collaço LM; Araújo SR; Huçulak M; Boza EJ; Fischer RM; De Laat L; Sobbania LC; Raggio A
Diagn Cytopathol; 2003 Jul; 29(1):49-54. PubMed ID: 12827718
[TBL] [Abstract][Full Text] [Related]
25. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
26. [Cytological history of cases of invasive cervical cancer diagnosed in France in 2006].
Boulanger JC; Fauvet R; Urrutiaguer S; Drean Y; Sevestre H; Ganry O; Bergeron C; Gondry J
Gynecol Obstet Fertil; 2007 Sep; 35(9):764-71. PubMed ID: 17765001
[TBL] [Abstract][Full Text] [Related]
27. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
28. [Effectiveness of cytology-based cervical cancer screening in the Colombian health system].
Murillo R; Cendales R; Wiesner C; Piñeros M; Tovar S
Biomedica; 2009 Sep; 29(3):354-61. PubMed ID: 20436987
[TBL] [Abstract][Full Text] [Related]
29. Cytological screening for cervical cancer in the province of Limburg, Belgium.
Arbyn M; Van Nieuwenhuyse A; Bogers J; De Jonge E; De Beeck LO; Matheï C; Buntinx F
Eur J Cancer Prev; 2011 Jan; 20(1):18-24. PubMed ID: 20805755
[TBL] [Abstract][Full Text] [Related]
30. Hispanic acculturation and utilization of cervical cancer screening in the US.
Shah M; Zhu K; Wu H; Potter J
Prev Med; 2006 Feb; 42(2):146-9. PubMed ID: 16297444
[TBL] [Abstract][Full Text] [Related]
31. [The significance of the combined usage of cytology and the HPV test in cervical cancer screening].
Kina K; Ishi K; Hashizume A; Saeki H; Shiono S; Nagai F; Nojima M
Rinsho Byori; 2009 Sep; 57(9):913-7. PubMed ID: 19860221
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
34. Risk of cervical cancer subsequent to a positive screening cytology: follow-up study in Finland.
Viikki M; Pukkala E; Hakama M
Acta Obstet Gynecol Scand; 2000 Jul; 79(7):576-9. PubMed ID: 10929958
[TBL] [Abstract][Full Text] [Related]
35. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
36. 1991 cervical screening recommendations: a working group report.
Paul C; Bagshaw S; Bonita R; Durham G; Fitzgerald NW; Jones RW; Marshall B; McAvoy BR
N Z Med J; 1991 Jul; 104(915):291-5. PubMed ID: 1906587
[TBL] [Abstract][Full Text] [Related]
37. Papanicolaou smear screening of women with intellectual disabilities: a cross-sectional survey in Taiwan.
Lin LP; Lin JD; Sung CL; Liu TW; Liu YL; Chen LM; Chu CM
Res Dev Disabil; 2010; 31(2):403-9. PubMed ID: 19897337
[TBL] [Abstract][Full Text] [Related]
38. [Developments in mass screening for uterine cancer in the past 10 years (1972-1981) in Shimane Prefecture--cell sampling method and the central cytological diagnostic system].
Iwanari O; Matsunaga I; Moriyama M; Takahashi K; Kitao M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jul; 36(7):1008-16. PubMed ID: 6747385
[TBL] [Abstract][Full Text] [Related]
39. [Studies on the appropriated interval of mass screening for cervical cancer].
Kusanagi T; Kudo R; Ito E; Sagae S; Hori Y; Tamura H; Hayakawa O; Fujimura Y; Hashimoto M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jun; 35(6):782-6. PubMed ID: 6875333
[TBL] [Abstract][Full Text] [Related]
40. [Survey of screening for uterine cervical cancer in Wakayama city (author's transl)].
Yokota H; Mabuchi Y; Hosomichi T
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Dec; 33(12):2072-8. PubMed ID: 7338660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
